Publication details
Increasing the infliximab dose in rheumatoid arthritis patients: a randomized, double blind study failed to confirm its efficacy.
| Authors | |
|---|---|
| Year of publication | 2009 |
| Type | Article in Periodical |
| Magazine / Source | Annals of the Rheumatic Diseases |
| MU Faculty or unit | |
| Citation | |
| Field | Other medical specializations |
| Keywords | rheumatoid arthritis; therapy; infliximab; dose escalation |
| Description | In this study, increasing the infliximab dose from 3 to 5 mg/kg in RA patients with residual disease activity did not improve efficacy but moderately increased toxicity. These data indicate that a switch to another biological treatment would be a more appropriate strategy in incomplete responders. |